Enibarcimab (Anti-Adrenomedullin)

Enibarcimab (Anti-Adrenomedullin) is a humanised murine monoclonal immunoglobulin G1 (IgG1) antibody targeting the vasoprotective peptide adrenomedullin. It can be used for acute heart failure, COVID-19 infections and septic shock research. MW : 145.5 KD.
Supplier Selleck Chemicals
Product # A2593
Sku # A2593-1mg
Pricing 1mg, $539.00
Feedback